Atlas Trials

A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response

Clinical trial NCT05051943 · COMPLETED

Trial details

NCT number
NCT05051943
Sponsor
Fresenius Kabi
Status
COMPLETED
Study type
OBSERVATIONAL
Crohn DiseaseUlcerative ColitisPsoriasisAnkylosing SpondylitisRheumatoid ArthritisPsoriatic Arthritis
Start date
2020-09-29
Primary completion
2023-01-20
Enrollment
754

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.